SHARP tweaked: "Statistical plan" changed in ongoing ezetimibe/simvastatin trial - TheHeart.Org Print
TheHeart.OrgOxford, UK - The evaluation of the efficacy of lipid-lowering therapy with ezetimibe/simvastatin (Vytorin, Merck) in the Study of Heart and Renal Protection

... read more